Essex Savings Bank Edwards Lifesciences Corp Transaction History

Essex Savings Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$86.5 - $128.27 $150,769 - $223,574	-1,743 Closed	0 $0
Q4 2021 Feb 23, 2022	SELL	$106.37 - $130.68 $15,423 - $18,948	-145 Reduced 7.68%	1,743 $226,000
Q3 2021 Oct 20, 2021	BUY	$102.91 - $122.75 $194,294 - $231,752	1,888 New	1,888 $222,000
Q3 2019 Oct 30, 2019	SELL	$61.55 - $75.43 $34,775 - $42,617	-565 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$55.74 - $64.41 $16,443 - $19,000	295 Added 109.26%	565 $104,000
Q4 2018 Feb 01, 2019	BUY	$46.41 - $56.94 $12,530 - $15,373	270 New	270 $41,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Essex Savings Bank, based on Form 13F filings with the SEC.

Stay updated on Essex Savings Bank with notifications on news.